Pulling SEC filings + quote and writing the call…

ARVINAS, INC.
Next earnings Aug 4, 2026 · consensus $-0.55 EPS, $36.2M rev
Last earnings -0.9% on 2026-05-12
Conservative balance sheet (liabilities/equity 0.65x); but revenue declined -0.3% YoY.
ARVINAS, INC. shows $263M in FY2025 revenue (-0.3% YoY), a -30.8% net margin, and -18.6% ROE.
Sources: SEC EDGAR (CIK 0001655759, latest 10-Q filed 2026-05-11) · EODHD · as of 6/26/2026, 6:42:05 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $53.6M | $131M | $78.5M | $263M | $263M |
| Gross profit | — | — | — | — | — |
| Operating income | -$188M | -$263M | -$402M | -$250M | -$119M |
| Net income | -$191M | -$283M | -$367M | -$199M | -$80.8M |
| Diluted EPS | -$3.82 | -$5.31 | -$6.62 | -$2.77 | -$1.14 |
| Net margin | -356.3% | -215.0% | -467.9% | -75.5% | -30.8% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
1049 tracked peers · median
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Last 90 days: 0 open-market buys · 2 sales
| 2026-06-24 | Smaldone Alsup Laurie Director | Award | 15.5K | |
| 2026-06-24 | Norwalk Leslie V Director | Award | 15.5K | |
| 2026-06-24 | Morrison Briggs Director | Award | 15.5K | |
| 2026-06-24 | Kennedy Edward Moore Jr. Director | Award | 15.5K | |
| 2026-06-24 | Cunningham Everett Director | Award | 15.5K | |
| 2026-06-24 | Bain Linda Director | Award | 15.5K | |
| 2026-06-24 | Saik Andrew Chief Financial Officer | Sell | 5.70K @ $8.16 | $46.5K |
| 2026-06-17 | Cacace Angela M Chief Scientific Officer | Sell | 2.58K @ $7.60 | $19.6K |
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.